Metropolis Healthcare Reports Strong Operational Performance in Q1FY27
Metropolis Healthcare Limited released a business update detailing its operational performance for the quarter ended June 30, 2026. The company highlighted significant growth and margin improvements across various segments during Q1 of FY27.The consolidated review indicated that revenue grew by approximately 16% year-on-year (Y-o-Y). This growth was primarily attributed to increased patient volumes, supplemented by realization benefits derived from changes in the product mix.
Segment Growth and Business Drivers
The TruHealth Wellness segment and Specialty segments were identified as the fastest growing areas for the company during the quarter.Operations across customer segments showed robust performance:
- B2C Sector: Registered healthy volume growth, driven by increased throughput resulting from the expansion of the center network.
- B2B Sector: Experienced volume growth, which was supported by securing a higher wallet share and acquiring new customers. This success was bolstered by improved service quality and delivery levels provided by Metropolis Healthcare Limited.
Margin Performance
Metropolis Healthcare Limited noted that EBITDA margins improved on a year-on-year basis, aligning with prior guidance. However, when assessed on a quarter-on-quarter (Q-o-Q) basis, the company's margins remained largely stable.The quarterly business update is provided on a consolidated basis, and the financial results for Q1FY27 remain subject to review by Auditors.
METROPOLIS Stock Price Movement
Metropolis Healthcare Limited shares gained 2.14% on Friday, settling at ₹556 as trading concluded for the session. The stock traded within an intraday band ranging from a low of ₹544.3 to a high of ₹559.1.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.